About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Boston | 1,052 Studies

Clinical Trials Breast CancerBoston

Breast Cancer Clinical Trials in Boston

Find 1,052 clinical trials for breast cancer near Boston, Massachusetts. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Boston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 421-440 of 1,052 trials

RecruitingTesting the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast CancerThis phase I trial tests the safety, side effects, and best dose of ZEN003694 in combination with binimetinib in treating patients with solid tumors that carry RAS alterations and…NCT05111561·Boston, Massachusetts and 3 others CompletedEffects of Exercise Intervention on Insulin Levels in Breast Cancer SurvivorsThe purpose of this study is to determine whether an exercise program comprised of strength and endurance training will lower fasting insulin levels in a group of breast cancer…NCT00153894·Boston, Massachusetts CompletedStudy Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast CancerThis research study is studying Ruxolitinib as possible treatment for Inflammatory Breast Cancer (IBC). The Following drugs will be use in combination with Ruxolinitinib.NCT02876302·Boston, Massachusetts and 3 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

UnknownRadiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the BreastHypotheses: 1.NCT00470236·Campbelltown, New South Wales and 119 others

CompletedA Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies.Assessment of safety and efficacy of SU11248 in patients with metastatic breast cancer who have failed selected other therapies.NCT00078000·Greenbrae, California and 9 others

CompletedPegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast CancerThe main purpose of this study is to see if pegfilgrastim (Neulasta) is safe and useful in supporting people through dose-dense chemotherapy, and to see if a long-acting red blood…NCT00146562·Boston, Massachusetts and 5 others

CompletedAirXpanders AeroForm Tissue Expander System for Breast ReconstructionThis study is designed to allow existing investigators continued access to the AeroForm Tissue Expander to treat patients while AirXpanders completes a marketing application and…NCT02504424·Greenbrae, California and 7 others

CompletedAnalysis of Surgery in Patients Presenting With Stage IV Breast CancerThe purpose of this study is to study patients presenting with stage IV breast cancer.NCT00941759·Birmingham, Alabama and 19 others

TerminatedA Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor ReceptorThis is an open-label, Phase I, dose escalation study to determine the recommended Phase 2 dose, maximum tolerated dose, and evaluate the safety and pharmacokinetic profile of…NCT02365662·Boston, Massachusetts and 4 others

CompletedDocetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast CancerRATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of breast cancer cells, either by killing the cells or by stopping them from dividing.NCT01547741·Anchorage, Alaska and 914 others

Approved for marketingExpanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) ActivationExpanded access for participants with cancer with RET activation who are ineligible for an ongoing selpercatinib (also known as LOXO-292) clinical trial or have other…NCT03906331·Goodyear, Arizona and 63 others

RecruitingA Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast CancerThe efficacy and safety of zanidatamab in combination with physician's choice of chemotherapy compared with trastuzumab in combination with physician's choice of chemotherapy will…NCT06435429·Phoenix, Arizona and 165 others

TerminatedReal-Time Assessment Of Breast Cancer Surgical Specimen Margins With Nonlinear MicroscopyThis research is studying a new investigative imaging instrument called a nonlinear microscope (NLM).NCT02926729·Boston, Massachusetts

CompletedTykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast CancerThis study was designed to evaluate and compare the safety and efficacy of an oral dual tyrosine kinase inhibitor, lapatinib, versus placebo in women with early-stage…NCT00374322·Tuscaloosa, Alabama and 438 others

CompletedStudy of Neoadjuvant Olaparib Monotherapy and Olaparib and Durvalumab Combination in HER2 Negative BRCAm Breast CancerThis study to learn more about olaparib and olaparib plus durvalumab combination therapy and also to better understand the studied disease, breast cancer, and associated health…NCT05498155·Loveland, Colorado and 35 others

RecruitingRibociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast CancerThis is an open label, multicenter, single arm phase II study to evaluate the efficacy and safety of ribociclib and ET in patients with locoregional recurrence of HR-positive…NCT05467891·Birmingham, Alabama and 20 others

CompletedEducational Interventions for Patients With DCISThe purpose of this study is to determine whether adding an educational intervention, in the form of a decision board, which outlines the risks and benefits of treatment options…NCT00148655·Boston, Massachusetts and 1 other

Active not recruitingFirst-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)This study is one single group of participants with non-small cell lung cancer (NSCLC) who have not been cured by other treatments.NCT03401385·Los Angeles, California and 17 others

RecruitingShorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast CancerThis phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple…NCT05929768·Birmingham, Alabama and 962 others

Active not recruitingStudy of Oral MRT-2359 in Selected Cancer PatientsThis Phase 1/2, open-label, multicenter study is conducted in patients with previously treated selected solid tumors, including non-small cell lung cancer (NSCLC), small cell lung…NCT05546268·Scottsdale, Arizona and 16 others

PreviousPage 22 of 53Next

Other Conditions in Boston

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma